Skip to main content

Publications

Publications

A targeted review of NICE, CADTH and ICER assessments: An evaluation of the Joint Position Statement

Andreas Charalambous, Elise Evers, Andrew Mumford

Published on 10 June 2024
An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

Reece Coleman, Jonathan Gibson, Harry Lewis, and Andrew Mumford

Published on 9 June 2025
Key issues in health economic analysis in NICE Highly Specialised Technology appraisals

Harry Lewis, Andrew Mumford, David Ringger

Published on 1 June 2022
The Cost-Effectiveness of Immunotherapies for Advanced Biliary Tract Carcinoma: A PRISMA Systematic Literature Review

Charlotte Ahmadu, Sarah Coyle, Jonathan Gibson and Tiyi Morris

Published on 21 March 2025
Estimating the true cost of weight-based chemotherapy

Janice Cheng, Tom Edmonds, Andrew Mumford, Georgia Roberts

Published on 1 December 2022
Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis

Charlotte Ahmadu, Tom Edmonds, and Oliver Darlington

Published on 9 June 2025

Listen to our podcast: Initiation

Working with Initiate | What to expect working with our market access and health economics consultancy | Initiation Podcast

Developing PROMs in rare diseases | A conversation with Benson Chen from MitoCAMB | Initiation Podcast

Insights from the 2023 Reimbursement Radar wrap-up | Initiation Podcast

View more in Spotify

© Copyright 2025 Initiate Consultancy is a limited company.
Registered in England and Wales. Reg No. 11903774 | Privacy Policy

Let’s discuss your purpose

hello@initiateconsultancy.com
0203 759 0505